ACTIVE

Microbial Resource Management Health

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-9,5 M €-12,6 %over 1 year

Gross margin814,1 k €+119,6 %over 1 year

Equity6,9 M €+160,1 %over 1 year

Workforce22,8 ETP-24,5 %over 1 year

Identity

Source · BCE/KBO

Microbial Resource Management Health is a Public limited company incorporated in 2020. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 22,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0742.910.132
Incorporation: 04/02/2020
Legal form: Public limited company
Registered office: Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital: 36 709 633,32 €
Latest accounts: 31/12/2025
Average workforce: 22,8 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology 74909Other professional, scientific and technical activities n.e.c.74999Other professional, scientific and technical activities n.e.c.72109Research and experimental development on natural sciences and engineering 72190Other research and experimental development on natural sciences and engineering+4

Joint committees (1)

20700

Signals

Solid equityGood liquidityHealthy social debts

Financials

Source · NBB, 6 filings

Trend over 5 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	814,1 k €	+120%	-4,1 M €	-1.1%	-4,1 M €	-142%	-1,7 M €	+13.6%	-2 M €
EBITDA	-1,7 M €	+75.9%	-6,9 M €	-4.6%	-6,6 M €	-64.7%	-4 M €	-7.9%	-3,7 M €
Operating result	-8,9 M €	-17.8%	-7,6 M €	-5.7%	-7,2 M €	-61.1%	-4,4 M €	-8.3%	-4,1 M €
Net result	-9,5 M €	-12.6%	-8,5 M €	-13.5%	-7,5 M €	-66.5%	-4,5 M €	-8.6%	-4,1 M €
Balance sheet
Equity	6,9 M €	+160%	-11,5 M €	-275%	-3,1 M €	-170%	4,4 M €	-17.5%	5,3 M €
Total assets	11,7 M €	+214%	3,7 M €	-56.7%	8,6 M €	+9.0%	7,9 M €	+8.1%	7,3 M €
Cash	8,1 M €	+817%	886,3 k €	-64.6%	2,5 M €	-24.3%	3,3 M €	-28.3%	4,6 M €
Debts	4,7 M €	-65.5%	13,7 M €	+35.9%	10,1 M €	+550%	1,6 M €	-13.6%	1,8 M €
Other
Workforce	22,8 ETP	-24.5%	30,2 ETP	+2.7%	29,4 ETP	+15.3%	25,5 ETP	+19.2%	21,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Lenny Van Steenhuyse	Director22/10/2025 → 10/06/2031
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by Goedele Ertveldt	Director01/10/2025 → 10/06/2031
David Devigne	Director20/08/2025 → 10/06/2031
Jean-Patrick Hennebelle	Director20/08/2025 → 10/06/2031
Julian Zachman	Director20/08/2025 → 10/06/2031
Sam Possemiers	Director04/02/2020 → 10/06/2031

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Oliver Hasselwander	Director02/03/2022 → 2024 accounts
Rubli LLC0775.914.282Represented by Werner CAUTREELS	Director10/06/2021 → 2021 accounts
Rubli LLCRepresented by Werner Cautreels	Director10/06/2021 → 2024 accounts
Jens Van Nieuwenborgh	Director14/02/2020 → 2024 accounts

Other companies at this address

Technologiepark-Zwijnaarde 82 9052 Gent

Company	CBE no.
Amalus Therapeutics● Bankrupt	0803.929.268
APCOR R&M● Active	0600.952.909
Ardoyen● Active	0875.102.821
AVROXA● Active	0687.774.936
Benebiose● Active	0784.521.548
BioNeering● Active	0807.194.309
CONTREL EUROPE● Active	0426.204.637
CRODEON TECHNOLOGIES● Active	0642.754.761
Cryptobiotix● Active	0762.565.104
Gulliver Biomed● Active	0692.527.837
ImplicitMeasures.com● Bankrupt	0657.989.701
Inbiose● Active	0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active	0440.054.752
INNOVATIVE PHARMACEUTICS● Active	0883.574.582
Inspect● Active	0645.950.417
INVIBES ADVERTISING● Active	0836.533.938
KYTOS● Active	0768.755.286
Lares Solutions● Active	1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active	0755.350.975
Microbial Resource Management Technologies● Active	0667.765.816

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	04/02/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	11 months
Filing date	14/07/2026	14/08/2025	11/07/2024	27/06/2023	28/06/2022	06/07/2021
General meeting	30/06/2026	02/07/2025	13/06/2024	10/06/2023	09/06/2022	10/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	14/07/2026	Dutch	PDF
Abridged model	31/12/2024	02/07/2025	14/08/2025	Dutch	PDF
Abridged model	31/12/2023	13/06/2024	11/07/2024	Dutch	PDF
Abridged model	31/12/2022	10/06/2023	27/06/2023	Dutch	PDF
Abridged model	31/12/2021	09/06/2022	28/06/2022	Dutch	PDF
Abridged model	31/12/2020	10/06/2021	06/07/2021	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Lenny Van Steenhuyse	Director22/10/2025 → 10/06/2031
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by Goedele Ertveldt	Director01/10/2025 → 10/06/2031
David Devigne	Director20/08/2025 → 10/06/2031
Jean-Patrick Hennebelle	Director20/08/2025 → 10/06/2031
Julian Zachman	Director20/08/2025 → 10/06/2031
Sam Possemiers	Director04/02/2020 → 10/06/2031

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Oliver Hasselwander	Director02/03/2022 → 2024 accounts
Rubli LLC0775.914.282Represented by Werner CAUTREELS	Director10/06/2021 → 2021 accounts
Rubli LLCRepresented by Werner Cautreels	Director10/06/2021 → 2024 accounts
Jens Van Nieuwenborgh	Director14/02/2020 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates06/10/2026
Ontslag en benoeming bestuurders — Benoeming voorzitter
PDF
Mandates01/06/2026
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares22/10/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN
PDF
Mandates25/09/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/09/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Other28/06/2023
DIVERSEN
PDF
Mandates07/04/2023
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares28/12/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings5 filings

Mandates

Lenny Van Steenhuyse

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Sam Possemiers

Julian Zachman

Jean-Patrick Hennebelle

David Devigne

Oliver Hasselwander

Rubli LLC

Jens Van Nieuwenborgh

Sebastien Guery

KORYS INVESTMENTS

202020212022202320242025202620272028202920302031

Microbial Resource Management Health

Technologiepark-Zwijnaarde 82, 9052 Zwijnaarde

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Technologiepark-Zwijnaarde 82, 9052 ZwijnaardeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00296025

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Microbial Resource Management HealthCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00296025

Events

2025
Annual accounts 2025-9,5 M €↓
2024
Annual accounts 2024-8,5 M €↓
2023
Annual accounts 2023-7,5 M €↓
2022
Annual accounts 2022-4,5 M €↓
2021
Annual accounts 2021-4,1 M €
04/02/2020
IncorporationPublic limited company

Microbial Resource Management Health

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events